Stockscreener 앱 받기
16.77
1.21%
0.20
시간 외 거래:
16.77
전일 마감가:
$16.57
열려 있는:
$16.55
하루 거래량:
739.53K
Relative Volume:
0.41
시가총액:
$1.14B
수익:
$2.66B
순이익/손실:
$-1.21B
주가수익비율:
-0.9411
EPS:
-17.82
순현금흐름:
$-159.40M
1주 성능:
+4.49%
1개월 성능:
-4.25%
6개월 성능:
-38.28%
1년 성능:
-27.15%
1일 변동 폭
$16.00
$16.86
1주일 범위
$16.00
$17.51
52주 변동 폭
$9.92
$35.58
Quidelortho Corp Stock (QDEL) Company Profile
명칭
Quidelortho Corp
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
16.77 | 1.15B | 2.66B | -1.21B | -159.40M | -17.82 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-09-19 | 재개 | UBS | Neutral |
| 2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
| 2022-09-19 | 개시 | Citigroup | Neutral |
| 2022-07-20 | 개시 | UBS | Sell |
| 2022-06-17 | 재개 | JP Morgan | Neutral |
| 2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | 재확인 | Barclays | Overweight |
| 2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
| 2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | 재확인 | Canaccord Genuity | Hold |
| 2017-02-17 | 개시 | CL King | Neutral |
| 2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | 재확인 | Barclays | Overweight |
| 2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | 개시 | Barclays | Overweight |
| 2013-07-31 | 재확인 | Canaccord Genuity | Buy |
| 2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corp 주식(QDEL)의 최신 뉴스
QuidelOrtho to Report Second Quarter 2026 Financial Results - marketscreener.com
QuidelOrtho Corp (QDEL) Institutional Confidence - TradingKey
QuidelOrtho Corp (QDEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
QuidelOrtho Corp (QDEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
QuidelOrtho Corp (QDEL) Balance Sheet - TradingKey
QDEL|QuidelOrtho Corp|Price:16.840| - TradingKey
QuidelOrtho Corp (QDEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
QuidelOrtho Corp (QDEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
QuidelOrtho Corp (QDEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QuidelOrtho Corporation (QDEL) to Release Q2 Financial Results S - GuruFocus
QuidelOrtho Results Will Arrive After Market Close Aug. 6 - Stock Titan
QuidelOrtho Corp (QDEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Reasons to Add QuidelOrtho Stock in Your Portfolio for Now - Yahoo Finance
Beyond Fentanyl: How the Drug Crisis Is Changing – Company Announcement - Financial Times
QuidelOrtho Corp (QDEL) Shares Fall 4.5% -- What GF Score of 43 Tells Investors - GuruFocus
Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway - TradingView
QuidelOrtho (QDEL) 7th Annual Evercore ISI HealthCONx Conference Summary - Quartr
A Look at QuidelOrtho Corp (QDEL) After 4.8% Decline -- GF Value $37.34 vs Price $17.37 - GuruFocus
QuidelOrtho (QDEL) Files A Share Shelf, Is The Stock Still Cheap? - simplywall.st
QuidelOrtho reports inducement grant - Medical Buyer
QuidelOrtho Corp (QDEL) awards 356,555 restricted stock units to CFO - Stock Titan
QuidelOrtho CFO Micah Young Receives 356,555 Stock Units - Stock Titan
QuidelOrtho Corp (NASDAQ: QDEL) CFO reports zero stock ownership on Form 3 - Stock Titan
Frontier tech research, news & data - MLQ.ai
NEUBERGER BERMAN GROUP LLC Acquires Additional Shares in QuidelO - GuruFocus
QuidelOrtho taps former Masimo executive Micah Young as CFO - MSN
QuidelOrtho (QDEL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
QuidelOrtho Corp (QDEL) Shares Surge 4.8% -- What GF Score of 43 Tells Investors - GuruFocus
QuidelOrtho (QDEL) Is Down 5.1% After Broad Russell Growth Index RemovalWhat's Changed - simplywall.st
Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1 - Yahoo Finance
Neuberger Berman holds 3.53M shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho: Too Much Uncertainty Around Earnings Keeping Short-Interest Elevated (QDEL) - Seeking Alpha
Citi Maintains QuidelOrtho(QDEL.US) With Hold Rating, Raises Target Price to $18 - Moomoo
QuidelOrtho Corp highlights diagnostics portfolio as investors track Nasdaq listing - ad-hoc-news.de
QDEL stock eyes best day in over a year — point-of-care sale talks ignite rally - MSN
QuidelOrtho (QDEL) moves 32.2% higher: Will this strength last? - MSN
Jefferies downgrades QuidelOrtho (QDEL) - MSN
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Officer Hanson Bryan Michael - Moomoo
QDELQuidelOrtho Corp Earnings - Finviz
QuidelOrtho (QDEL) EVP Hanson converts 5,797 RSUs, 2,096 shares withheld for taxes - Stock Titan
QDEL Maintained by JP Morgan -- Price Target Raised to $12.00 - GuruFocus
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $12 - Moomoo
Is QuidelOrtho Corp (QDEL) a Bargain After 3.9% Drop? GF Value S - GuruFocus
QuidelOrtho Corp. Opens with 21.32% Gain Amid Ongoing Financial Challenges - MarketsMojo
Stocks making big moves yesterday: AppLovin, QuidelOrtho, Rocket Lab, Pinterest, and Zscaler - Barchart.com
QuidelOrtho (QDEL) Moves 32.2% Higher: Will This Strength Last? - Yahoo Finance
Does QuidelOrtho's (QDEL) Index Exit and New CFO Hint at a Shift in Growth Identity? - Yahoo Finance
QuidelOrtho (QDEL) stock trades up, here is why - MSN
Form 4 Quidel Corporation For: 29 June By Investing.com - Investing.com Canada
QuidelOrtho | 4: Statement of changes in beneficial ownership of securities-Director WIDDER KENNETH J - Moomoo
QuidelOrtho (QDEL) director receives 15,532 restricted stock units as equity award - Stock Titan
Quidelortho Corp (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Quidelortho Corp 주식 (QDEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Strobeck Matthew | Director |
Feb 13 '26 |
Buy |
23.96 |
10,000 |
239,586 |
27,775 |
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
1.04%
11.95%
자본화:
|
볼륨(24시간):